account_num,net_change,tag,tag_depth,cik
2673,-36747000.0,EmployeeRelatedLiabilitiesCurrent,2,842023_BIO-TECHNE CORP
802,18715000.0,AssetImpairmentCharges,1,842023_BIO-TECHNE CORP
2764,-23069000.0,ContractWithCustomerLiabilityCurrent,3,842023_BIO-TECHNE CORP
825,18715000.0,GoodwillAndIntangibleAssetImpairment,2,842023_BIO-TECHNE CORP
3315,-5000000.0,BusinessCombinationContingentConsiderationLiabilityNoncurrent,4,842023_BIO-TECHNE CORP
2676,-3500000.0,BusinessCombinationContingentConsiderationLiabilityCurrent,4,842023_BIO-TECHNE CORP
375,92493000.0,ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost,2,842023_BIO-TECHNE CORP
1455,-11682000.0,GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee,1,842023_BIO-TECHNE CORP
1781,-11682000.0,NonoperatingGainsLosses,1,842023_BIO-TECHNE CORP
2710,-23069000.0,DeferredRevenueCurrent,2,842023_BIO-TECHNE CORP
2431,179000.0,NetIncomeLossAttributableToNoncontrollingInterest,1,842023_BIO-TECHNE CORP
2091,2017210000.0,AssetsNoncurrent,2,842023_BIO-TECHNE CORP
2089,2638692000.0,Assets,1,842023_BIO-TECHNE CORP
2398,-25679000.0,AccountsPayableCurrent,2,842023_BIO-TECHNE CORP
2347,-40559000.0,AccountsPayableAndAccruedLiabilitiesCurrent,3,842023_BIO-TECHNE CORP
2737,-12500000.0,LongTermDebtAndCapitalLeaseObligationsCurrent,3,842023_BIO-TECHNE CORP
2638,-12500000.0,DebtCurrent,2,842023_BIO-TECHNE CORP
3017,-1413000.0,OtherLiabilitiesCurrent,2,842023_BIO-TECHNE CORP
2041,285302000.0,OtherAssetsNoncurrent,2,842023_BIO-TECHNE CORP
3154,-128509000.0,LiabilitiesCurrent,2,842023_BIO-TECHNE CORP
3379,-93766000.0,OperatingLeaseLiabilityNoncurrent,3,842023_BIO-TECHNE CORP
3796,-198667000.0,LiabilitiesOtherThanLongtermDebtNoncurrent,3,842023_BIO-TECHNE CORP
3645,-548667000.0,LiabilitiesNoncurrent,2,842023_BIO-TECHNE CORP
3465,-677176000.0,Liabilities,1,842023_BIO-TECHNE CORP
3661,-1576000.0,CommonStockValue,3,842023_BIO-TECHNE CORP
3750,-721543000.0,AdditionalPaidInCapital,1,842023_BIO-TECHNE CORP
3834,-1309461000.0,RetainedEarningsAccumulatedDeficit,1,842023_BIO-TECHNE CORP
3303,-350000000.0,LongTermDebtAndCapitalLeaseObligations,2,842023_BIO-TECHNE CORP
3316,-1966516000.0,StockholdersEquity,1,842023_BIO-TECHNE CORP
1827,1407382000.0,IntangibleAssetsNetIncludingGoodwill,2,842023_BIO-TECHNE CORP
1368,226200000.0,PropertyPlantAndEquipmentNet,4,842023_BIO-TECHNE CORP
645,180571000.0,CashAndCashEquivalentsAtCarryingValue,3,842023_BIO-TECHNE CORP
1732,534645000.0,IntangibleAssetsNetExcludingGoodwill,2,842023_BIO-TECHNE CORP
577,204310000.0,CashCashEquivalentsAndShortTermInvestments,4,842023_BIO-TECHNE CORP
229,218468000.0,AccountsReceivableNetCurrent,3,842023_BIO-TECHNE CORP
207,218468000.0,AccountsNotesAndLoansReceivableNetCurrent,4,842023_BIO-TECHNE CORP
320,218468000.0,ReceivablesNetCurrent,3,842023_BIO-TECHNE CORP
455,171638000.0,InventoryNet,2,842023_BIO-TECHNE CORP
260,171638000.0,InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings,4,842023_BIO-TECHNE CORP
868,621482000.0,AssetsCurrent,2,842023_BIO-TECHNE CORP
1634,98326000.0,OperatingLeaseRightOfUseAsset,2,842023_BIO-TECHNE CORP
59,-4738000.0,AllowanceForDoubtfulAccountsReceivableCurrent,3,842023_BIO-TECHNE CORP
1133,18715000.0,RestructuringSettlementAndImpairmentProvisions,3,842023_BIO-TECHNE CORP
3260,-1966516000.0,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,2,842023_BIO-TECHNE CORP
232,-769815000.0,GrossProfit,1,842023_BIO-TECHNE CORP
3383,-88982000.0,DeferredIncomeTaxLiabilitiesNet,2,842023_BIO-TECHNE CORP
3494,-10919000.0,OtherLiabilitiesNoncurrent,2,842023_BIO-TECHNE CORP
3733,-721543000.0,AdditionalPaidInCapitalCommonStock,2,842023_BIO-TECHNE CORP
3809,-66064000.0,AccumulatedOtherComprehensiveIncomeLossNetOfTax,2,842023_BIO-TECHNE CORP
171,366887000.0,CostOfGoodsAndServicesSold,2,842023_BIO-TECHNE CORP
144,366887000.0,CostOfRevenue,1,842023_BIO-TECHNE CORP
491,92493000.0,ResearchAndDevelopmentExpense,2,842023_BIO-TECHNE CORP
2552,-14880000.0,AccruedLiabilitiesCurrent,2,842023_BIO-TECHNE CORP
581,111208000.0,OperatingCostsAndExpenses,2,842023_BIO-TECHNE CORP
1478,-1143000.0,IncomeLossFromEquityMethodInvestments,1,842023_BIO-TECHNE CORP
110,-1136702000.0,RevenueFromContractWithCustomerExcludingAssessedTax,2,842023_BIO-TECHNE CORP
2603,-1136702000.0,NoninterestIncome,1,842023_BIO-TECHNE CORP
757,27066000.0,OtherAssetsCurrent,2,842023_BIO-TECHNE CORP
2877,-12022000.0,AccruedIncomeTaxesCurrent,2,842023_BIO-TECHNE CORP
2841,-12022000.0,TaxesPayableCurrent,2,842023_BIO-TECHNE CORP
3853,-759000.0,MinorityInterest,1,842023_BIO-TECHNE CORP
2004,-47520000.0,OtherNonoperatingIncomeExpense,1,842023_BIO-TECHNE CORP
3917,-2638692000.0,LiabilitiesAndStockholdersEquity,2,842023_BIO-TECHNE CORP
281,23739000.0,ShortTermInvestments,1,842023_BIO-TECHNE CORP
2716,-12500000.0,LongTermDebtCurrent,2,842023_BIO-TECHNE CORP
601,378378000.0,SellingGeneralAndAdministrativeExpense,3,842023_BIO-TECHNE CORP
1112,470871000.0,OperatingExpenses,1,842023_BIO-TECHNE CORP
1264,-298944000.0,OperatingIncomeLoss,1,842023_BIO-TECHNE CORP
1665,-3410000.0,InvestmentIncomeNet,2,842023_BIO-TECHNE CORP
1205,-15092000.0,InvestmentIncomeNonoperating,2,842023_BIO-TECHNE CORP
2130,-39715000.0,NonoperatingIncomeExpense,1,842023_BIO-TECHNE CORP
1709,11215000.0,InterestExpense,1,842023_BIO-TECHNE CORP
1854,11215000.0,InterestAndDebtExpense,2,842023_BIO-TECHNE CORP
2257,-338659000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,2,842023_BIO-TECHNE CORP
2399,53217000.0,IncomeTaxExpenseBenefit,1,842023_BIO-TECHNE CORP
1820,-391876000.0,IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest,3,842023_BIO-TECHNE CORP
1077,-285442000.0,ProfitLoss,2,842023_BIO-TECHNE CORP
1912,-285263000.0,NetIncomeLoss,1,842023_BIO-TECHNE CORP
2590,-285263000.0,NetIncomeLossAvailableToCommonStockholdersBasic,2,842023_BIO-TECHNE CORP
2903,-285263000.0,NetIncomeLossAvailableToCommonStockholdersDiluted,2,842023_BIO-TECHNE CORP
2149,-349874000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,3,842023_BIO-TECHNE CORP
1711,872737000.0,Goodwill,1,842023_BIO-TECHNE CORP
